MERLINI, ESTHER
 Distribuzione geografica
Continente #
EU - Europa 3.423
NA - Nord America 2.948
AS - Asia 2.222
SA - Sud America 230
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 10
Totale 8.889
Nazione #
US - Stati Uniti d'America 2.838
GB - Regno Unito 1.235
IT - Italia 989
CN - Cina 706
SG - Singapore 561
HK - Hong Kong 279
DE - Germania 239
BD - Bangladesh 232
RU - Federazione Russa 176
SE - Svezia 175
BR - Brasile 170
NL - Olanda 130
VN - Vietnam 124
FR - Francia 105
CA - Canada 92
IE - Irlanda 78
FI - Finlandia 69
IN - India 68
TR - Turchia 59
ID - Indonesia 45
UA - Ucraina 37
KR - Corea 34
DK - Danimarca 30
JP - Giappone 28
BE - Belgio 24
CH - Svizzera 21
ES - Italia 21
PL - Polonia 21
EU - Europa 19
GR - Grecia 16
CO - Colombia 15
AR - Argentina 14
CI - Costa d'Avorio 10
TW - Taiwan 10
AT - Austria 9
AU - Australia 9
EC - Ecuador 9
IQ - Iraq 9
MX - Messico 9
ET - Etiopia 8
IR - Iran 8
PK - Pakistan 8
RO - Romania 8
TH - Thailandia 8
ZA - Sudafrica 8
VE - Venezuela 7
CL - Cile 6
HU - Ungheria 6
LU - Lussemburgo 6
MA - Marocco 5
PH - Filippine 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
MY - Malesia 4
NO - Norvegia 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
JO - Giordania 3
NP - Nepal 3
PE - Perù 3
RS - Serbia 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MD - Moldavia 2
MM - Myanmar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
HT - Haiti 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MU - Mauritius 1
MV - Maldive 1
NZ - Nuova Zelanda 1
Totale 8.899
Città #
Southend 1.149
Singapore 328
Ashburn 303
Hong Kong 262
Chandler 207
Milan 165
Fairfield 164
Beijing 131
San Jose 123
Seattle 123
Ann Arbor 112
Council Bluffs 107
Wilmington 106
Dallas 93
Woodbridge 93
Houston 92
Dublin 77
Los Angeles 72
Dearborn 71
Princeton 71
The Dalles 71
New York 65
Santa Clara 63
Cambridge 59
Boardman 54
Toronto 51
Helsinki 41
Ho Chi Minh City 38
Jakarta 37
Rome 37
Frankfurt am Main 35
Hanoi 35
Lauterbourg 32
Buffalo 30
Mountain View 30
Des Moines 28
Nanjing 27
Columbus 26
Shanghai 25
Phoenix 24
Moscow 22
Brussels 21
Redwood City 21
Hangzhou 20
Naples 20
Guangzhou 19
Redmond 18
Tianjin 18
Bengaluru 17
Montréal 17
Turin 17
Chicago 16
Kiez 16
Mumbai 15
Saint Petersburg 14
Wuhan 14
Grafing 13
Nuremberg 13
San Diego 13
Tokyo 13
Warsaw 13
Changsha 12
Fremont 12
Istanbul 12
Jinan 12
Sakarya 12
São Paulo 12
Fuzhou 11
Shenyang 11
Abidjan 10
Atlanta 10
Berlin 10
Florence 10
Seoul 10
Amsterdam 9
Andover 9
Cangzhou 9
Eau Claire 9
Shenzhen 9
Athens 8
Hefei 8
London 8
Silver Spring 8
Bogotá 7
Boston 7
Brooklyn 7
Hebei 7
Jacksonville 7
Orem 7
Taipei 7
Zurich 7
Belo Horizonte 6
Charlotte 6
Da Nang 6
Falls Church 6
Haiphong 6
Luxembourg 6
Madrid 6
Margão 6
Misterbianco 6
Totale 5.338
Nome #
Mapping the human genetic architecture of COVID-19 1.180
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 417
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial 378
T-Cell Phenotypes, Apoptosis and Inflammation in HIV+ Patients on Virologically Effective cART with Early Atherosclerosis 371
STUDIO DELLA TRASLOCAZIONE DI MACROMOLECOLE MICROBICHE E DEI RESERVOIR VIRALI COME POSSIBILI MECCANISMI PATOGENETICI DI MANCATO RECUPERO DI CD4 IN SOGGETTI HIV-POSITIVI 357
Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression 328
Reduced central memory CD4+ T cells and increased T-Cell activation characterise treatment-naive patients newly diagnosed at late stage of HIV infection 322
Increased bone marrow interleukin-7 (IL-7)/IL-7R levels but reduced IL-7 responsiveness in HIV-Positive patients lacking CD4+ gain on antiviral therapy 319
Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature 306
Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy 302
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART 300
Invariant Natural Killer T (iNKT) cells in HAART-treated, HIV-positive patients with bone and cardiovascular impairment 292
Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression : 48-week efficacy and safety results 290
Viro-immunological characterization of naïve patients with high cerebrospinal fluid (CSF) HIV RNA 263
Efficacy of Maraviroc (MVC) as intensification strategy in immunological non-responder (INR) HIV-1-infected patients treated with HAART 251
Association between CSF and peripheral markers of immune-activation/inflammation and elevated intrathecal HIV-RNA levels in a cohort of HIV-infected antiretroviral naıve individuals 251
Role of in vitro stimulation with lipopolysaccharide on T-Cell activation in HIV-infected antiretroviral-treated patients 250
Biomarkers of aging in HIV: inflammation and the microbiome 244
Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naïve HIV-infected patients 231
CD8+ hyperactivation and senescence correlate with early carotid intima-media thickness in HIV+ patients with no cardiovascular disease 230
Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy 217
Predictors of low ovarian reserve in cART-treated women living with HIV 212
Sequencing of bacterial microflora in peripheral blood: our experience with HIV-infected patients 211
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count 207
Atazanavir/ritonavir monotherapy : 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 207
Soluble CD163 in CMV Infected and Uninfected subjects on Virologically-Suppressive Antiretroviral therapy in the ICONA cohort 192
Immune activation, inflammation and HIV DNA after 96-weeks of ATV/r monotherapy : a MODAt substudy 188
Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies 182
Immune reconstitution in HIV+ subjects on Lopinavir/Ritonavir-based HAART according to the severity of pre-therapy CD4+ 177
Successful direct-acting antiviral therapy in HIV/HCV co-infected patients fails to restore circulating mucosal-associated invariant T cells 160
Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART) 152
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV 118
Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy 107
Totale 9.212
Categoria #
all - tutte 23.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022769 75 51 49 35 28 29 43 64 94 124 61 116
2022/2023832 84 99 88 89 85 115 42 46 102 17 43 22
2023/2024519 33 42 32 61 106 45 50 31 9 22 32 56
2024/20251.130 45 100 34 125 69 62 58 103 96 82 123 233
2025/20262.792 231 136 167 139 216 199 353 190 274 219 401 267
2026/202713 13 0 0 0 0 0 0 0 0 0 0 0
Totale 9.212